ARRY-382

Overview

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC 50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > c-Fms

Product Information

• Catalog No.: HY-136362
• CAS No.: 1313407-95-2
• Molecular Formula: C32H36N8O2
• Molecular Weight: 564.68
• Purity: 99.95%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 0.83 mg/mL (1.47 mM); Clear solution
• Availability: In-stock

Source

Original product source